Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study. by Turner, R, Millns, H, Holman, R

An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study by Richards, D, Millns, H, Cookson, L, Lukas, MA

Risk factors for stroke in non-insulin dependent diabetic subjects. by Millns, H, Stratton, I, Holman, R, Turner, R

Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. by Davis, T, Millns, H, Stratton, I, Holman, R, Turner, R

Risk factors for coronary heart disease in non-insulin dependent diabetic subjects by Turner, R, Millns, H, Stratton, I, Neil, H, Holman, R

Sequence variations in the human Kir6.2 gene, a subunit of the beta-cell ATP-sensitive K-channel: no association with NIDDM in while Caucasian subjects or evidence of abnormal func... by Sakura, H, Wat, N, Horton, V, Millns, H, Turner, R, Ashcroft, F

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) by Turner, R, Millns, H, Neil, H, Stratton, I, Manley, SE, Matthews, DR, Holman, R

Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an... by Wechalekar, A, Antoni, G, Al Azzam, W, Bergström, M, Biswas, S, Chen, C, Cheriyan, J, Cleveland, M, Cookson, L, Galette, P, Janiczek, RL, Kwong, RY, Lukas, MA, Millns, H, Richards, D, Schneider, I, Solomon, SD, Sörensen, J, Storey, J, Thompson, D, van Dongen, G, Vugts, DJ, Wall, A, Wikström, G, Falk, RH